🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Researchers are looking for new ways to treat Limited-Stage Small Cell Lung...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0007)
Start Date
2020-12-08
Trial ID
NCT04624204
This is a Phase III randomised, double-blind, multi-centre study to evaluat...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-01-04
Trial ID
NCT03737643
Treatments Being Tested
To assess the efficacy of olaparib when given in combination with paclitaxe...
Status
Completed
Location
Research Site
Start Date
2010-02-02
Trial ID
NCT01063517
Treatments Being Tested
The OReO study will be a Phase IIIb, randomised, double-blind, placebo-cont...
Status
Completed
Location
Research Site
Start Date
2017-06-08
Trial ID
NCT03106987
Treatments Being Tested
A study to assess the efficacy and safety of durvalumab in combination with...
Status
Active Not Recruiting
Location
Research Site
Start Date
2020-05-05
Trial ID
NCT04269200
Treatments Being Tested
Olaparib treatment in patients with germline BRCA1/2 mutations and high ris...
Status
Active Not Recruiting
Location
Research Site
Start Date
2014-04-22
Trial ID
NCT02032823
Study Title: A Multicenter, Randomized Controlled Trial of Tiaoshen Anti-ca...
Status
Not Yet Recruiting
Location
Shanghai Hospital of Traditional Chinese Medicine
Start Date
2026-05-01
Trial ID
NCT07550205
A Phase III, randomised, double-blind, placebo-controlled, multi-centre stu...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2013-09-03
Trial ID
NCT01874353
Treatments Being Tested
The primary purpose of this study to determine if AZD2281 is effective and ...
Status
Completed
Location
Research Site
Start Date
2008-08-28
Trial ID
NCT00753545
Treatments Being Tested
A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Stud...
Status
Completed
Location
Research Site
Start Date
2014-12-16
Trial ID
NCT02184195